Reaction
Incisional Hernia reporting signals
As of the last recalculation, Incisional Hernia appears in 1,370 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 15.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 14 | 15.9 | 16.0 |
| Niraparib | 21 | 14.6 | 14.6 |
| Diphenoxylate Hydrochloride And Atropine Sulfate | 12 | 13.4 | 13.4 |
| Granisetron Hydrochloride | 9 | 13.2 | 13.2 |
| Granisetron | 9 | 13.1 | 13.1 |
| Everolimus Tablets | 14 | 12.8 | 12.8 |
| Sirolimus | 9 | 10.2 | 10.2 |
| Mycophenolic Acid | 21 | 10.1 | 10.1 |
| Vedolizumab | 51 | 9.3 | 9.3 |
| Adalimumab | 311 | 8.3 | 8.3 |
| Daptomycin | 5 | 8.3 | 8.3 |
| Bevacizumab | 56 | 7.1 | 7.1 |
| Isotretinoin | 14 | 4.3 | 4.3 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 2.0 | 2.0 |